October 24, 2011 – Kambiz Dowlat, M.D., founder of Novian Health, has been honored by the Chicagoland-area affiliate of Susan G. Komen for the Cure in the inaugural class of Pink Tie Guys. Dowlat, developer of Novilase image-guided laser therapy for breast tumors, is one of what the organization called "an exclusive group of KoMEN making a difference in the fight against breast cancer."
The Pink Tie Guys, who were nominated by the community and selected by the Komen Chicagoland Board of Directors, were honored Oct. 13 at Tribune Media Group's Pink Tie Gala attended by Illinois Gov. Pat Quinn. In addition to Dowlat, former Chicago Mayor Richard M. Daley was among the honorees.
"This prestigious award demonstrates yet again the value of Dowlat's research. It's a gratifying recognition of his longstanding dedication to improving women's breast health,” said Henry "Chip" Appelbaum, president and CEO of Novian Health. Dowlat, a professor of surgery at Rush University Medical Center, is a pioneer of minimally invasive breast cancer procedures. He performed the groundbreaking research that formed the basis for the multi-center breast cancer trial that Novian is launching, having recently received approval of an investigational device (IDE) from the U.S. Food and Drug Administration (FDA). Novian developed the Novilase ILT System for the ablation of small (up to 20 mm) malignant breast tumors. The company has previously received FDA 510(k) clearance for the treatment of breast fibroadenomas and currently offers Novilase at breast centers around the country that are participating in its ABLATE registry.
The Chicagoland affiliate of Susan G. Komen for the Cure was established in 1997 and held the first Susan G. Komen Chicago Race for the Cure. The affiliate has awarded nearly $11 million towards the fight against breast cancer by funding grassroots breast health education and breast cancer screening and treatment projects, as well as national research.
For more information: www.novianhealth.com
April 16, 2024 
